Echeverria, L. E., Demacq, C., Gimpelewicz, C., McMurray, J. J. V., Lopes, R. D., & on behalf of the PARACHUTE‐HF Investigators. (2025). Reply to the letter regarding the article 'Sacubitril/valsartan versus enalapril in chronic Chagas cardiomyopathy with heart failure: Baseline characteristics of the PARACHUTE-HF trial'. Eur J Heart Fail. https://doi.org/10.1002/ejhf.70062

Echeverria, Luis Eduardo, Caroline Demacq, Claudio Gimpelewicz, John J. V. McMurray, Renato Delascio Lopes, and on behalf of the PARACHUTE‐HF Investigators. “Reply to the letter regarding the article 'Sacubitril/valsartan versus enalapril in chronic Chagas cardiomyopathy with heart failure: Baseline characteristics of the PARACHUTE-HF trial'.” Eur J Heart Fail, October 14, 2025. https://doi.org/10.1002/ejhf.70062.

Echeverria LE, Demacq C, Gimpelewicz C, McMurray JJV, Lopes RD, on behalf of the PARACHUTE‐HF Investigators. Reply to the letter regarding the article 'Sacubitril/valsartan versus enalapril in chronic Chagas cardiomyopathy with heart failure: Baseline characteristics of the PARACHUTE-HF trial'. Eur J Heart Fail. 2025 Oct 14;

Echeverria, Luis Eduardo, et al. “Reply to the letter regarding the article 'Sacubitril/valsartan versus enalapril in chronic Chagas cardiomyopathy with heart failure: Baseline characteristics of the PARACHUTE-HF trial'.” Eur J Heart Fail, Oct. 2025. Pubmed, doi:10.1002/ejhf.70062.

Echeverria LE, Demacq C, Gimpelewicz C, McMurray JJV, Lopes RD, on behalf of the PARACHUTE‐HF Investigators. Reply to the letter regarding the article 'Sacubitril/valsartan versus enalapril in chronic Chagas cardiomyopathy with heart failure: Baseline characteristics of the PARACHUTE-HF trial'. Eur J Heart Fail. 2025 Oct 14;